Methotrexate
NDC 0378-0014, methotrexate, tablet, from Mylan Pharmaceuticals Inc..
- Product NDC
- 0378-0014
- Status
- Listed
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA081235
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0378-0014 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHOTREXATE SODIUM2.5 mg/1
Pharmacologic classes
Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0378-0014-01 | 00378001401 | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0014-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/70c09984-2b36-424f-8b27-3fd0cd4e833dMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0378-0014NADAC price for package 00378001401
GET /v1/drugs/nadac/00378001401
Use it
Look up 0378-0014 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0378-0014 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0378-0014. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.